{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:30:24Z","timestamp":1790605824736,"version":"4.1.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40121-025-01281-5","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T09:18:58Z","timestamp":1766308738000},"page":"443-459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Meningococcal Disease in Older Adults: Challenges in Diagnosis and Management"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-3174","authenticated-orcid":false,"given":"Muhamed-Kheir","family":"Taha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-1945","authenticated-orcid":false,"given":"Catherine","family":"Weil-Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2690-8055","authenticated-orcid":false,"given":"Sean","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-0134","authenticated-orcid":false,"given":"Ener Cagri","family":"Dinleyici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3380-7092","authenticated-orcid":false,"given":"Saber","family":"Yezli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"issue":"21","key":"1281_CR1","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.vaccine.2019.04.020","volume":"37","author":"B Wang","year":"2019","unstructured":"Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37(21):2768\u201382. https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.020.","journal-title":"Vaccine"},{"issue":"6","key":"1281_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106335","volume":"89","author":"R Borrow","year":"2024","unstructured":"Borrow R, Campbell H, Caugant DA, Cherkaoui A, Claus H, Deghmane AE, et al. Global meningococcal initiative: insights on antibiotic resistance, control strategies and advocacy efforts in Western Europe. J Infect. 2024;89(6):106335. https:\/\/doi.org\/10.1016\/j.jinf.2024.106335.","journal-title":"J Infect"},{"issue":"18","key":"1281_CR3","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1016\/j.vaccine.2011.02.058","volume":"29","author":"LH Harrison","year":"2011","unstructured":"Harrison LH, Pelton SI, Wilder-Smith A, Holst J, Safadi MA, Vazquez JA, et al. The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine. 2011;29(18):3363\u201371. https:\/\/doi.org\/10.1016\/j.vaccine.2011.02.058.","journal-title":"Vaccine"},{"issue":"4","key":"1281_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","volume":"81","author":"SR Parikh","year":"2020","unstructured":"Parikh SR, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81(4):483\u201398. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.079.","journal-title":"J Infect"},{"issue":"1","key":"1281_CR5","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2186111","volume":"19","author":"MK Taha","year":"2023","unstructured":"Taha MK, Bekkat-Berkani R, Abitbol V. Changing patterns of invasive meningococcal disease and future immunization strategies. Hum Vaccin Immunother. 2023;19(1):2186111. https:\/\/doi.org\/10.1080\/21645515.2023.2186111.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"1281_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/14760584.2024.2329618","volume":"23","author":"R Borrow","year":"2024","unstructured":"Borrow R, Findlow J. The important lessons lurking in the history of meningococcal epidemiology. Expert Rev Vaccines. 2024;23(1):445\u201362. https:\/\/doi.org\/10.1080\/14760584.2024.2329618.","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"1281_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.43551","volume":"7","author":"T Shin","year":"2024","unstructured":"Shin T, Wells CR, Shoukat A, Potter-Schwartz L, Langevin E, Langley JM, et al. Quadrivalent conjugate vaccine and invasive meningococcal disease in US adolescents and young adults. JAMA Netw Open. 2024;7(11):e2443551. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.43551.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1281_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12889-022-12795-9","volume":"22","author":"S Guedes","year":"2022","unstructured":"Guedes S, Bertrand-Gerentes I, Evans K, Coste F, Oster P. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. BMC Public Health. 2022;22(1):380. https:\/\/doi.org\/10.1186\/s12889-022-12795-9.","journal-title":"BMC Public Health"},{"issue":"3","key":"1281_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s41999-024-00969-0","volume":"15","author":"C Weil-Olivier","year":"2024","unstructured":"Weil-Olivier C, Taha MK, Leng S, Dinleyici EC, Bonanni P, Moya E, et al. Invasive meningococcal disease in older adults: current perspectives and call for action. Eur Geriatr Med. 2024;15(3):729\u201341. https:\/\/doi.org\/10.1007\/s41999-024-00969-0.","journal-title":"Eur Geriatr Med"},{"issue":"6","key":"1281_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jinf.2017.02.011","volume":"74","author":"I du Parent Chatelet","year":"2017","unstructured":"du Parent Chatelet I, Deghmane AE, Antona D, Hong E, Fonteneau L, Taha MK, et al. Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015. J Infect. 2017;74(6):564\u201374. https:\/\/doi.org\/10.1016\/j.jinf.2017.02.011.","journal-title":"J Infect"},{"key":"1281_CR11","unstructured":"Sant\u00e9 Publique France. Les infections invasives \u00e0 m\u00e9ningocoque en France en 2023. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/maladies-a-prevention-vaccinale\/infections-invasives-a-meningocoque\/documents\/bulletin-national2\/infections-invasives-a-meningocoque-en-france-en-2023 Accessed 25 October 2024."},{"issue":"4","key":"1281_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40121-018-0213-2","volume":"7","author":"KJ Olbrich","year":"2018","unstructured":"Olbrich KJ, Muller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7(4):421\u201338. https:\/\/doi.org\/10.1007\/s40121-018-0213-2.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"1281_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228020","volume":"15","author":"L Huang","year":"2020","unstructured":"Huang L, Heuer OD, Janssen S, Hackl D, Schmedt N. Clinical and economic burden of invasive meningococcal disease: evidence from a large German claims database. PLoS ONE. 2020;15(1):e0228020. https:\/\/doi.org\/10.1371\/journal.pone.0228020.","journal-title":"PLoS ONE"},{"issue":"1","key":"1281_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2021764","volume":"18","author":"C Weil-Olivier","year":"2022","unstructured":"Weil-Olivier C, Taha MK, Bouee S, Emery C, Loncle-Provot V, Nachbaur G, et al. Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Hum Vaccin Immunother. 2022;18(1):e2021764. https:\/\/doi.org\/10.1080\/21645515.2021.2021764.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"1281_CR15","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s40121-021-00468-w","volume":"10","author":"C Weil-Olivier","year":"2021","unstructured":"Weil-Olivier C, Taha MK, Emery C, Bouee S, Beck E, Aris E, et al. Healthcare resource consumption and cost of invasive meningococcal disease in France: a study of the National Health Insurance Database. Infect Dis Ther. 2021;10(3):1607\u201323. https:\/\/doi.org\/10.1007\/s40121-021-00468-w.","journal-title":"Infect Dis Ther"},{"issue":"4","key":"1281_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1532-5415.2003.51152.x","volume":"51","author":"KE Covinsky","year":"2003","unstructured":"Covinsky KE, Palmer RM, Fortinsky RH, Counsell SR, Stewart AL, Kresevic D, et al. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc. 2003;51(4):451\u20138. https:\/\/doi.org\/10.1046\/j.1532-5415.2003.51152.x.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1281_CR17","doi-asserted-by":"publisher","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","volume":"30","author":"D Pace","year":"2012","unstructured":"Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(2):B3-9. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.062.","journal-title":"Vaccine"},{"issue":"2","key":"1281_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jinf.2019.11.001","volume":"80","author":"H Campbell","year":"2020","unstructured":"Campbell H, Andrews N, Parikh S, Ribeiro S, Gray S, Lucidarme J, et al. Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England. J Infect. 2020;80(2):182\u20139. https:\/\/doi.org\/10.1016\/j.jinf.2019.11.001.","journal-title":"J Infect"},{"issue":"1","key":"1281_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23744235.2021.1971289","volume":"54","author":"AE Deghmane","year":"2022","unstructured":"Deghmane AE, Taha S, Taha MK. Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review. Infect Dis. 2022;54(1):1\u20137. https:\/\/doi.org\/10.1080\/23744235.2021.1971289.","journal-title":"Infect Dis"},{"issue":"10","key":"1281_CR20","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s40121-023-00869-z","volume":"12","author":"I Bertrand-Gerentes","year":"2023","unstructured":"Bertrand-Gerentes I, Fanchon L, Coste F, Glover RE, Guiddir T, Taha MK. Range of clinical manifestations caused by invasive meningococcal disease due to serogroup W: a systematic review. Infect Dis Ther. 2023;12(10):2337\u201351. https:\/\/doi.org\/10.1007\/s40121-023-00869-z.","journal-title":"Infect Dis Ther"},{"issue":"12","key":"1281_CR21","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1086\/379719","volume":"37","author":"P Vienne","year":"2003","unstructured":"Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha MK, et al. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis. 2003;37(12):1639\u201342. https:\/\/doi.org\/10.1086\/379719.","journal-title":"Clin Infect Dis"},{"issue":"37","key":"1281_CR22","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1016\/j.vaccine.2016.07.013","volume":"34","author":"M Vossen","year":"2016","unstructured":"Vossen M, Mitteregger D, Steininger C. Meningococcal pneumonia. Vaccine. 2016;34(37):4364\u201370. https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.013.","journal-title":"Vaccine"},{"key":"1281_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-019-0062-0","volume":"11","author":"C Feldman","year":"2019","unstructured":"Feldman C, Anderson R. Meningococcal pneumonia: a review. Pneumonia. 2019;11:3. https:\/\/doi.org\/10.1186\/s41479-019-0062-0.","journal-title":"Pneumonia"},{"issue":"12","key":"1281_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jiac.2016.07.014","volume":"22","author":"J Hirai","year":"2016","unstructured":"Hirai J, Kinjo T, Tome T, Hagihara M, Sakanashi D, Nakamura H, et al. Meningococcal pneumonia in Japan: a case report and literature review. J Infect Chemother. 2016;22(12):833\u20136. https:\/\/doi.org\/10.1016\/j.jiac.2016.07.014.","journal-title":"J Infect Chemother"},{"key":"1281_CR25","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268821001035","volume":"149","author":"O Sall","year":"2021","unstructured":"Sall O, Stenmark B, Jacobsson S, Eriksson L, Thulin Hedberg S, Hertting O, et al. Atypical presentation of Neisseria meningitidis serogroup W disease is associated with the introduction of the 2013 strain. Epidemiol Infect. 2021;149:e126. https:\/\/doi.org\/10.1017\/S0950268821001035.","journal-title":"Epidemiol Infect"},{"key":"1281_CR26","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819002152","volume":"148","author":"C Stinson","year":"2020","unstructured":"Stinson C, Burman C, Presa J, Abalos M. Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci. Epidemiol Infect. 2020;148:e12. https:\/\/doi.org\/10.1017\/S0950268819002152.","journal-title":"Epidemiol Infect"},{"issue":"8","key":"1281_CR27","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/cid\/ciy257","volume":"67","author":"T Guiddir","year":"2018","unstructured":"Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, et al. Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis. 2018;67(8):1220\u20137. https:\/\/doi.org\/10.1093\/cid\/ciy257.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1281_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad615","volume":"11","author":"AE Deghmane","year":"2024","unstructured":"Deghmane AE, Taha S, Taha MK. Not only meningitis but also epiglottitis: an emerging clinical presentation of invasive meningococcal disease. Open Forum Infect Dis. 2024;11(1):ofad615. https:\/\/doi.org\/10.1093\/ofid\/ofad615.","journal-title":"Open Forum Infect Dis"},{"issue":"10240","key":"1281_CR29","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/S0140-6736(20)30913-2","volume":"395","author":"SN Ladhani","year":"2020","unstructured":"Ladhani SN, Lucidarme J, Parikh SR, Campbell H, Borrow R, Ramsay ME. Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis. Lancet. 2020;395(10240):1865\u201377. https:\/\/doi.org\/10.1016\/S0140-6736(20)30913-2.","journal-title":"Lancet"},{"issue":"4","key":"1281_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac035","volume":"9","author":"SE Oliver","year":"2022","unstructured":"Oliver SE, Retchless AC, Blain AE, McNamara LA, Ahrabifard S, Farley M, et al. Risk factors for invasive meningococcal disease belonging to a novel urethritis clade of Neisseria meningitidis-United States, 2013-2017. Open Forum Infect Dis. 2022;9(4):ofac035. https:\/\/doi.org\/10.1093\/ofid\/ofac035.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"1281_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jinf.2019.10.015","volume":"79","author":"SR Parikh","year":"2019","unstructured":"Parikh SR, Campbell H, Mandal S, Ramsay ME, Ladhani SN. Primary meningococcal conjunctivitis: summary of evidence for the clinical and public health management of cases and close contacts. J Infect. 2019;79(6):490\u20134. https:\/\/doi.org\/10.1016\/j.jinf.2019.10.015.","journal-title":"J Infect"},{"issue":"1","key":"1281_CR32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1186\/s12879-024-09547-y","volume":"24","author":"S Taha","year":"2024","unstructured":"Taha S, Deghmane AE, Taha MK. Recent increase in atypical presentations of invasive meningococcal disease in France. BMC Infect Dis. 2024;24(1):640. https:\/\/doi.org\/10.1186\/s12879-024-09547-y.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"1281_CR33","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1017\/S0950268817000929","volume":"145","author":"O Sall","year":"2017","unstructured":"Sall O, Stenmark B, Glimaker M, Jacobsson S, Molling P, Olcen P, et al. Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, 1995 to 2012. Epidemiol Infect. 2017;145(10):2137\u201343. https:\/\/doi.org\/10.1017\/S0950268817000929.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"1281_CR34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jinf.2022.07.019","volume":"85","author":"G Gyamfi-Brobbey","year":"2022","unstructured":"Gyamfi-Brobbey G, Clark SA, Campbell H, Lekshmi A, Ribeiro S, Walker A, et al. An analysis of Neisseria meningitidis strains causing meningococcal septic arthritis in England and Wales: 2010-2020. J Infect. 2022;85(4):390\u20136. https:\/\/doi.org\/10.1016\/j.jinf.2022.07.019.","journal-title":"J Infect"},{"issue":"12","key":"1281_CR35","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.jiph.2023.10.001","volume":"16","author":"S Taha","year":"2023","unstructured":"Taha S, Hong E, Denizon M, Falguieres M, Terrade A, Deghmane AE, et al. The rapid rebound of invasive meningococcal disease in France at the end of 2022. J Infect Public Health. 2023;16(12):1954\u201360. https:\/\/doi.org\/10.1016\/j.jiph.2023.10.001.","journal-title":"J Infect Public Health"},{"issue":"5","key":"1281_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/15353702211057473","volume":"247","author":"S Rattanaburi","year":"2022","unstructured":"Rattanaburi S, Sawaswong V, Chitcharoen S, Sivapornnukul P, Nimsamer P, Suntronwong N, et al. Bacterial microbiota in upper respiratory tract of COVID-19 and influenza patients. Exp Biol Med Maywood. 2022;247(5):409\u201315. https:\/\/doi.org\/10.1177\/15353702211057473.","journal-title":"Exp Biol Med Maywood"},{"issue":"11","key":"1281_CR37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3345\/cep.2020.01452","volume":"64","author":"HM Kang","year":"2021","unstructured":"Kang HM, Kang JH. Effects of nasopharyngeal microbiota in respiratory infections and allergies. Clin Exp Pediatr. 2021;64(11):543\u201351. https:\/\/doi.org\/10.3345\/cep.2020.01452.","journal-title":"Clin Exp Pediatr"},{"key":"1281_CR38","unstructured":"US Centers for Disease Control and Prevention (CDC). Risk Factors for Meningococcal Disease. https:\/\/www.cdc.gov\/meningococcal\/risk-factors\/index.html Accessed 6 November 2024."},{"key":"1281_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2022.03.032","volume":"119","author":"H Dubey","year":"2022","unstructured":"Dubey H, Oster P, Fazeli MS, Guedes S, Serafini P, Leung L, et al. Risk factors for contracting invasive meningococcal disease and related mortality: a systematic literature review and meta-analysis. Int J Infect Dis. 2022;119:1\u20139. https:\/\/doi.org\/10.1016\/j.ijid.2022.03.032.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"1281_CR40","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1080\/21645515.2020.1849518","volume":"17","author":"MK Taha","year":"2021","unstructured":"Taha MK, Weil-Olivier C, Bouee S, Emery C, Nachbaur G, Pribil C, et al. Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Hum Vaccin Immunother. 2021;17(6):1858\u201366. https:\/\/doi.org\/10.1080\/21645515.2020.1849518.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"1281_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/cid\/ciab856","volume":"75","author":"LF Lundbo","year":"2022","unstructured":"Lundbo LF, Harboe ZB, Sandholdt H, Smith-Hansen L, Valentiner-Branth P, Hoffmann S, et al. Comorbidity increases the risk of invasive meningococcal disease in adults. Clin Infect Dis. 2022;75(1):125\u201330. https:\/\/doi.org\/10.1093\/cid\/ciab856.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1281_CR42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s12879-019-4146-5","volume":"19","author":"SN Ladhani","year":"2019","unstructured":"Ladhani SN, Campbell H, Lucidarme J, Gray S, Parikh S, Willerton L, et al. Invasive meningococcal disease in patients with complement deficiencies: a case series (2008\u20132017). BMC Infect Dis. 2019;19(1):522. https:\/\/doi.org\/10.1186\/s12879-019-4146-5.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1281_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad696","volume":"11","author":"KC Rudmann","year":"2024","unstructured":"Rudmann KC, Cooper G, Marjuki H, Reingold A, Barnes M, Petit S, et al. Meningococcal disease in persons with HIV reported through active surveillance in the United States, 2009-2019. Open Forum Infect Dis. 2024;11(1):ofad696. https:\/\/doi.org\/10.1093\/ofid\/ofad696.","journal-title":"Open Forum Infect Dis"},{"issue":"24","key":"1281_CR44","doi-asserted-by":"publisher","first-page":"663","DOI":"10.15585\/mmwr.mm7224a4","volume":"72","author":"AB Rubis","year":"2023","unstructured":"Rubis AB, Howie RL, Marasini D, Sharma S, Marjuki H, McNamara LA. Notes from the field: increase in meningococcal disease among persons with HIV - United States, 2022. MMWR Morb Mortal Wkly Rep. 2023;72(24):663\u20134. https:\/\/doi.org\/10.15585\/mmwr.mm7224a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1281_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2024-056269","author":"L Rabuszko","year":"2024","unstructured":"Rabuszko L, Stuart-George S, Chessell C, Fitzpatrick C, Williams D, Richardson D. Invasive Neisseria meningitidis subtype C in gay, bisexual and other men who have sex with men: a systematic review. Sex Transm Infect. 2024. https:\/\/doi.org\/10.1136\/sextrans-2024-056269.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"1281_CR46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12889-022-12933-3","volume":"22","author":"S Guedes","year":"2022","unstructured":"Guedes S, Bricout H, Langevin E, Tong S, Bertrand-Gerentes I. Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis. BMC Public Health. 2022;22(1):521. https:\/\/doi.org\/10.1186\/s12889-022-12933-3.","journal-title":"BMC Public Health"},{"issue":"12","key":"1281_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad607","volume":"10","author":"LM Weil","year":"2023","unstructured":"Weil LM, Crowe SJ, Rubis AB, Soeters HM, Meyer SA, Hariri S, et al. Risk factors for serogroup B meningococcal disease among college students. Open Forum Infect Dis. 2023;10(12):ofad607. https:\/\/doi.org\/10.1093\/ofid\/ofad607.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"1281_CR48","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1186\/s12889-024-19740-y","volume":"24","author":"BR Morello","year":"2024","unstructured":"Morello BR, Milazzo A, Marshall HS, Giles LC. Public health management of invasive meningococcal disease outbreaks: worldwide 1973\u20132018, a systematic review. BMC Public Health. 2024;24(1):2254. https:\/\/doi.org\/10.1186\/s12889-024-19740-y.","journal-title":"BMC Public Health"},{"issue":"3","key":"1281_CR49","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3201\/eid2503.181574","volume":"25","author":"HM Soeters","year":"2019","unstructured":"Soeters HM, McNamara LA, Blain AE, Whaley M, MacNeil JR, Hariri S, et al. University-based outbreaks of meningococcal disease caused by serogroup B, United States, 2013\u20132018. Emerg Infect Dis. 2019;25(3):434\u201340. https:\/\/doi.org\/10.3201\/eid2503.181574.","journal-title":"Emerg Infect Dis"},{"issue":"23","key":"1281_CR50","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.23.1900070","volume":"24","author":"J Lawler","year":"2019","unstructured":"Lawler J, Lucidarme J, Parikh S, Smith L, Campbell H, Borrow R, et al. Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015. Euro Surveill. 2019;24(23):1900070. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.23.1900070.","journal-title":"Euro Surveill"},{"issue":"5","key":"1281_CR51","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3201\/eid3005.231714","volume":"30","author":"E Loud","year":"2024","unstructured":"Loud E, Clark SA, Edwards DS, Knapper E, Emmett L, Ladhani S, et al. Serogroup B invasive meningococcal disease in older adults identified by genomic surveillance, England, 2022-2023. Emerg Infect Dis. 2024;30(5):1009\u201312. https:\/\/doi.org\/10.3201\/eid3005.231714.","journal-title":"Emerg Infect Dis"},{"key":"1281_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijid.2015.12.010","volume":"47","author":"S Yezli","year":"2016","unstructured":"Yezli S, Bin Saeed AA, Assiri AM, Alhakeem RF, Yunus MA, Turkistani AM, et al. Prevention of meningococcal disease during the Hajj and Umrah mass gatherings: past and current measures and future prospects. Int J Infect Dis. 2016;47:71\u20138. https:\/\/doi.org\/10.1016\/j.ijid.2015.12.010.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"1281_CR53","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s40121-021-00499-3","volume":"10","author":"L Soumahoro","year":"2021","unstructured":"Soumahoro L, Abitbol V, Vicic N, Bekkat-Berkani R, Safadi MAP. Meningococcal disease outbreaks: a moving target and a case for routine preventative vaccination. Infect Dis Ther. 2021;10(4):1949\u201388. https:\/\/doi.org\/10.1007\/s40121-021-00499-3.","journal-title":"Infect Dis Ther"},{"issue":"4","key":"1281_CR54","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jinf.2020.08.030","volume":"81","author":"L Willerton","year":"2020","unstructured":"Willerton L, Lucidarme J, Campbell H, Caugant DA, Claus H, Jacobsson S, et al. Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complex. J Infect. 2020;81(4):575\u201384. https:\/\/doi.org\/10.1016\/j.jinf.2020.08.030.","journal-title":"J Infect"},{"key":"1281_CR55","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7322e1","author":"MS Vachon","year":"2024","unstructured":"Vachon MS, Barret AS, Lucidarme J, Neatherlin J, Rubis AB, Howie RL, et al. Cases of meningococcal disease associated with travel to Saudi Arabia for Umrah pilgrimage - United States, United Kingdom, and France, 2024. MMWR Morb Mortal Wkly Rep. 2024. https:\/\/doi.org\/10.15585\/mmwr.mm7322e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"1281_CR56","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/14760584.2022.2052048","volume":"21","author":"MK Taha","year":"2022","unstructured":"Taha MK, Martinon-Torres F, Kollges R, Bonanni P, Safadi MAP, Booy R, et al. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease. Expert Rev Vaccines. 2022;21(5):659\u201374. https:\/\/doi.org\/10.1080\/14760584.2022.2052048.","journal-title":"Expert Rev Vaccines"},{"key":"1281_CR57","unstructured":"US Centers for Disease Control and Prevention (CDC). Enhanced Meningococcal Disease Surveillance Report. 2022. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2022-508.pdf Accessed 6 November 2024."},{"issue":"26","key":"1281_CR58","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1016\/j.vaccine.2018.02.038","volume":"36","author":"SR Parikh","year":"2018","unstructured":"Parikh SR, Campbell H, Gray SJ, Beebeejaun K, Ribeiro S, Borrow R, et al. Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010\u20132015. Vaccine. 2018;36(26):3876\u201381. https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.038.","journal-title":"Vaccine"},{"issue":"14","key":"1281_CR59","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1017\/S0950268816001308","volume":"144","author":"JA Vazquez","year":"2016","unstructured":"Vazquez JA, Taha MK, Findlow J, Gupta S, Borrow R. Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease. Epidemiol Infect. 2016;144(14):3052\u20137. https:\/\/doi.org\/10.1017\/S0950268816001308.","journal-title":"Epidemiol Infect"},{"key":"1281_CR60","unstructured":"European Centre for Disease Prevention and Control (ECDC). Factsheet about meningococcal disease. https:\/\/www.ecdc.europa.eu\/en\/meningococcal-disease\/factsheet Accessed 25 October 2024."},{"issue":"11","key":"1281_CR61","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/imj.14102","volume":"48","author":"N Young","year":"2018","unstructured":"Young N, Thomas M. Meningitis in adults: diagnosis and management. Intern Med J. 2018;48(11):1294\u2013307. https:\/\/doi.org\/10.1111\/imj.14102.","journal-title":"Intern Med J"},{"key":"1281_CR62","unstructured":"National Institute for Health and Care Excellence (NICE). Pneumonia in adults: diagnosis and management. Clinical guideline, 2024."},{"issue":"1","key":"1281_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1148\/radiology.190.1.8259414","volume":"190","author":"MJ Brown","year":"1994","unstructured":"Brown MJ, Miller RR, Muller NL. Acute lung disease in the immunocompromised host: CT and pathologic examination findings. Radiology. 1994;190(1):247\u201354. https:\/\/doi.org\/10.1148\/radiology.190.1.8259414.","journal-title":"Radiology"},{"key":"1281_CR64","doi-asserted-by":"publisher","DOI":"10.1177\/23247096221111764","volume":"10","author":"M Valdez","year":"2022","unstructured":"Valdez M, Sharma R, Joshi J, Sandhu H, Mishra S, Kuran R, et al. A double whammy pneumonia: the first reported case of concurrent Neisseria meningitidis and SARS-CoV-2 pneumonia. J Investig Med High Impact Case Rep. 2022;10:23247096221111764. https:\/\/doi.org\/10.1177\/23247096221111764.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"1281_CR65","doi-asserted-by":"publisher","DOI":"10.37201\/req\/151.2021","author":"M Martin-Romero","year":"2022","unstructured":"Martin-Romero M, Clavero-Martinez D, Castillo-Navarro AM, Garcia-Vazquez E. Neisseria meningitidis bacteraemia and SARS-CoV-2 infection: a coinfection that reminds previous epidemic outbreaks. Rev Esp Quimioter. 2022. https:\/\/doi.org\/10.37201\/req\/151.2021.","journal-title":"Rev Esp Quimioter"},{"issue":"5","key":"1281_CR66","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39713","volume":"15","author":"C Espiche","year":"2023","unstructured":"Espiche C, Beltran M, Win Lei Y, Gil Castano Y, Francis-Morel G, Dahdouh M. Invasive meningococcal disease and COVID-19 co-infection: a case report. Cureus. 2023;15(5):e39713. https:\/\/doi.org\/10.7759\/cureus.39713.","journal-title":"Cureus"},{"key":"1281_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2022.e01656","volume":"31","author":"H Kojima","year":"2023","unstructured":"Kojima H, Nakamura-Uchiyama F, Ariyoshi T, Kosaka A, Washino T, Sakamoto N, et al. Non-serogroupable Neisseria meningitidis pneumonia in an immunocompetent patient with severe COVID-19 pneumonia: a case report. IDCases. 2023;31:e01656. https:\/\/doi.org\/10.1016\/j.idcr.2022.e01656.","journal-title":"IDCases"},{"key":"1281_CR68","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1281_CR69","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.chest.2020.07.089","volume":"158","author":"MW Pletz","year":"2020","unstructured":"Pletz MW, Blasi F, Chalmers JD, Dela Cruz CS, Feldman C, Luna CM, et al. International perspective on the New 2019 American Thoracic society\/infectious diseases Society of America Community-acquired pneumonia Guideline: a critical appraisal by a Global expert panel. Chest. 2020;158(5):1912\u20138. https:\/\/doi.org\/10.1016\/j.chest.2020.07.089.","journal-title":"Chest"},{"issue":"3","key":"1281_CR70","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-0042-101873","volume":"70","author":"S Ewig","year":"2016","unstructured":"Ewig S, Hoffken G, Kern WV, Rohde G, Flick H, Krause R, et al. Management of adult community-acquired pneumonia and prevention - Update 2016. Pneumologie. 2016;70(3):151\u2013200. https:\/\/doi.org\/10.1055\/s-0042-101873.","journal-title":"Pneumologie"},{"key":"1281_CR71","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.121434","author":"WS Lim","year":"2009","unstructured":"Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS Guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009. https:\/\/doi.org\/10.1136\/thx.2009.121434.","journal-title":"Thorax"},{"issue":"4","key":"1281_CR72","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/S2589-7500(24)00241-3","volume":"7","author":"D Shaw","year":"2025","unstructured":"Shaw D, Torreblanca RA, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, et al. The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance. Lancet Digit Health. 2025;7(4):e275\u201381. https:\/\/doi.org\/10.1016\/S2589-7500(24)00241-3.","journal-title":"Lancet Digit Health"},{"key":"1281_CR73","doi-asserted-by":"publisher","first-page":"1511086","DOI":"10.3389\/fped.2025.1511086","volume":"13","author":"E Ciftci","year":"2025","unstructured":"Ciftci E, Ocal D, Somer A, Tezer H, Yilmaz D, Bozkurt S, et al. Current methods in the diagnosis of invasive meningococcal disease. Front Pediatr. 2025;13:1511086. https:\/\/doi.org\/10.3389\/fped.2025.1511086.","journal-title":"Front Pediatr"},{"issue":"12","key":"1281_CR74","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","volume":"10","author":"H Christensen","year":"2010","unstructured":"Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853\u201361. https:\/\/doi.org\/10.1016\/S1473-3099(10)70251-6.","journal-title":"Lancet Infect Dis"},{"key":"1281_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2023.102581","volume":"53","author":"S Yezli","year":"2023","unstructured":"Yezli S, Yassin Y, Mushi A, Alabdullatif L, Alburayh M, Alotaibi BM, et al. Carriage of Neisseria meningitidis among travelers attending the Hajj pilgrimage, circulating serogroups, sequence types and antimicrobial susceptibility: a multinational longitudinal cohort study. Travel Med Infect Dis. 2023;53:102581. https:\/\/doi.org\/10.1016\/j.tmaid.2023.102581.","journal-title":"Travel Med Infect Dis"},{"issue":"2","key":"1281_CR76","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1164\/arrd.1987.135.2.426","volume":"135","author":"RA Salata","year":"1987","unstructured":"Salata RA, Lederman MM, Shlaes DM, Jacobs MR, Eckstein E, Tweardy D, et al. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis. 1987;135(2):426\u201332. https:\/\/doi.org\/10.1164\/arrd.1987.135.2.426.","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"1281_CR77","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00134-004-2270-0","volume":"30","author":"S Elatrous","year":"2004","unstructured":"Elatrous S, Boukef R, Ouanes Besbes L, Marghli S, Nooman S, Nouira S, et al. Diagnosis of ventilator-associated pneumonia: agreement between quantitative cultures of endotracheal aspiration and plugged telescoping catheter. Intensive Care Med. 2004;30(5):853\u20138. https:\/\/doi.org\/10.1007\/s00134-004-2270-0.","journal-title":"Intensive Care Med"},{"key":"1281_CR78","doi-asserted-by":"publisher","unstructured":"el-Ebiary M, Torres A, Gonzalez J, de la Bellacasa JP, Garcia C, Jimenez de Anta MT, et al. Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis. 1993;148(6 Pt 1):1552\u20137. https:\/\/doi.org\/10.1164\/ajrccm\/148.6_Pt_1.1552.","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1552"},{"issue":"11","key":"1281_CR79","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1128\/JCM.42.11.5146-5153.2004","volume":"42","author":"SP Yazdankhah","year":"2004","unstructured":"Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, Musilek M, et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol. 2004;42(11):5146\u201353. https:\/\/doi.org\/10.1128\/JCM.42.11.5146-5153.2004.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"1281_CR80","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.cmi.2018.09.015","volume":"25","author":"E Hong","year":"2019","unstructured":"Hong E, Bakhalek Y, Taha MK. Identification of Neisseria meningitidis by MALDI-TOF MS may not be reliable. Clin Microbiol Infect. 2019;25(6):717\u201322. https:\/\/doi.org\/10.1016\/j.cmi.2018.09.015.","journal-title":"Clin Microbiol Infect"},{"key":"1281_CR81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500245","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015. https:\/\/doi.org\/10.1056\/NEJMoa1500245.","journal-title":"N Engl J Med"},{"issue":"1","key":"1281_CR82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/14760584.2019.1557520","volume":"18","author":"R Acevedo","year":"2019","unstructured":"Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M, et al. The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019;18(1):15\u201330. https:\/\/doi.org\/10.1080\/14760584.2019.1557520.","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"1281_CR83","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1093\/infdis\/jiac095","volume":"225","author":"MK Taha","year":"2022","unstructured":"Taha MK, Deghmane AE. Evolution of resistance to antibiotics in Neisseria meningitidis: any reasons for concern? J Infect Dis. 2022;225(11):1869\u201370. https:\/\/doi.org\/10.1093\/infdis\/jiac095.","journal-title":"J Infect Dis"},{"issue":"6","key":"1281_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12060992","volume":"12","author":"AE Deghmane","year":"2023","unstructured":"Deghmane AE, Hong E, Taha MK. Recent evolution of susceptibility to beta-lactams in Neisseria meningitidis. Antibiotics. 2023;12(6):992. https:\/\/doi.org\/10.3390\/antibiotics12060992.","journal-title":"Antibiotics"},{"issue":"7","key":"1281_CR85","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/cid\/ciab358","volume":"73","author":"CC Potts","year":"2021","unstructured":"Potts CC, Retchless AC, McNamara LA, Marasini D, Reese N, Swint S, et al. Acquisition of ciprofloxacin resistance among an expanding clade of \u03b2-lactamase\u2013positive, serogroup Y Neisseria meningitidis in the United States. Clin Infect Dis. 2021;73(7):1185\u201393. https:\/\/doi.org\/10.1093\/cid\/ciab358.","journal-title":"Clin Infect Dis"},{"issue":"19","key":"1281_CR86","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.vaccine.2021.03.002","volume":"39","author":"L Willerton","year":"2021","unstructured":"Willerton L, Lucidarme J, Walker A, Lekshmi A, Clark SA, Gray SJ, et al. Increase in penicillin-resistant invasive meningococcal serogroup W ST-11 complex isolates in England. Vaccine. 2021;39(19):2719\u201329. https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.002.","journal-title":"Vaccine"},{"issue":"11","key":"1281_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260677","volume":"16","author":"L Willerton","year":"2021","unstructured":"Willerton L, Lucidarme J, Walker A, Lekshmi A, Clark SA, Walsh L, et al. Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010\/11 to 2018\/19). PLoS ONE. 2021;16(11):e0260677. https:\/\/doi.org\/10.1371\/journal.pone.0260677.","journal-title":"PLoS ONE"},{"issue":"3","key":"1281_CR88","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00627-22","volume":"10","author":"R Saito","year":"2022","unstructured":"Saito R, Nakajima J, Prah I, Morita M, Mahazu S, Ota Y, et al. Penicillin- and ciprofloxacin-resistant invasive Neisseria meningitidis Isolates from Japan. Microbiol Spectr. 2022;10(3):e0062722. https:\/\/doi.org\/10.1128\/spectrum.00627-22.","journal-title":"Microbiol Spectr"},{"key":"1281_CR89","doi-asserted-by":"publisher","unstructured":"McNamara LA, Potts C, Blain AE, Retchless AC, Reese N, Swint S, et al. Detection of ciprofloxacin-resistant, beta-lactamase-producing Neisseria meningitidis serogroup Y isolates - United States, 2019\u20132020. MMWR Morb Mortal Wkly Rep. 2020;69(24):735\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm6924a2.","DOI":"10.15585\/mmwr.mm6924a2"},{"issue":"1","key":"1281_CR90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/jac\/dkae433","volume":"80","author":"AE Deghmane","year":"2025","unstructured":"Deghmane AE, Taha S, Taha MK. Meningococcal resistance to ciprofloxacin is not rare anymore. J Antimicrob Chemother. 2025;80(1):311\u20133. https:\/\/doi.org\/10.1093\/jac\/dkae433.","journal-title":"J Antimicrob Chemother"},{"key":"1281_CR91","unstructured":"US Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. Chapter 8. Meningococcal disease. https:\/\/www.cdc.gov\/surv-manual\/php\/table-of-contents\/chapter-8-meningococcal-disease.html Accessed 6 November 2024."},{"key":"1281_CR92","unstructured":"European Centre for Disease Prevention and Control (ECDC). Public health management of sporadic cases of invasive meningococcal disease and their contacts. Stockholm: ECDC, 2010. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/public-health-guidance-management-sporadic-cases-invasive-meningococcal-disease Accessed 25 October 2024."},{"issue":"8","key":"1281_CR93","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jiph.2021.06.014","volume":"14","author":"BR Morello","year":"2021","unstructured":"Morello BR, Milazzo A, Marshall HS, Giles LC. Lessons for and from the COVID-19 pandemic response - an appraisal of guidance for the public health management of Invasive Meningococcal Disease. J Infect Public Health. 2021;14(8):1069\u201374. https:\/\/doi.org\/10.1016\/j.jiph.2021.06.014.","journal-title":"J Infect Public Health"},{"issue":"5","key":"1281_CR94","doi-asserted-by":"publisher","first-page":"99","DOI":"10.15585\/mmwr.mm7305a2","volume":"73","author":"I Berry","year":"2024","unstructured":"Berry I, Rubis AB, Howie RL, Sharma S, Marasini D, Marjuki H, et al. Selection of antibiotics as prophylaxis for close contacts of patients with meningococcal disease in areas with ciprofloxacin resistance - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;73(5):99\u2013103. https:\/\/doi.org\/10.15585\/mmwr.mm7305a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"1281_CR95","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1080\/14740338.2022.2147924","volume":"21","author":"C Bove","year":"2022","unstructured":"Bove C, Baldock RA, Champigneulle O, Martin L, Bennett CL. Fluoroquinolones: old drugs, putative new toxicities. Expert Opin Drug Saf. 2022;21(11):1365\u201378. https:\/\/doi.org\/10.1080\/14740338.2022.2147924.","journal-title":"Expert Opin Drug Saf"},{"key":"1281_CR96","unstructured":"US Centers for Disease Control and Prevention. Guidance for the Evaluation and Public Health Management of Suspected Outbreaks of Meningococcal Disease. v2.0, 2019. https:\/\/www.cdc.gov\/meningococcal\/downloads\/meningococcal-outbreak-guidance.pdf Accessed 6 November 2024."},{"key":"1281_CR97","unstructured":"European Centre for Disease Prevention and Control (ECDC). Invasive meningococcal disease, Annual epidemiological report for 2021. Stockholm: ECDC, 2023. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-meningococcal-disease-annual-epidemiological-report-2021 Accessed 25 October 2024."},{"key":"1281_CR98","unstructured":"European Centre for Disease Prevention and Control (ECDC). Invasive meningococcal disease, Annual epidemiological report for 2022. Stockholm: ECDC, 2024. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-meningococcal-disease-annual-epidemiological-report-2022 Accessed 25 October 2024."},{"key":"1281_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2018.e00466","volume":"14","author":"SD Zarbock","year":"2018","unstructured":"Zarbock SD, DePriest KL, Koepp BM. A case report of serotype W135 Neisseria meningitidis epiglottitis in the United States and review of twelve adult cases of meningococcal epiglottitis. IDCases. 2018;14:e00466. https:\/\/doi.org\/10.1016\/j.idcr.2018.e00466.","journal-title":"IDCases"},{"issue":"1","key":"1281_CR100","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/00365549509018978","volume":"27","author":"RS Crausman","year":"1995","unstructured":"Crausman RS, Pluss WT, Jennings CA. Acute epiglottitis in the adult caused by Neisseria meningitidis. Scand J Infect Dis. 1995;27(1):77\u20138. https:\/\/doi.org\/10.3109\/00365549509018978.","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"1281_CR101","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3201\/eid0503.990323","volume":"5","author":"E Schwam","year":"1999","unstructured":"Schwam E, Cox J. Fulminant meningococcal supraglottitis: an emerging infectious syndrome? Emerg Infect Dis. 1999;5(3):464\u20137. https:\/\/doi.org\/10.3201\/eid0503.990323.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"1281_CR102","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/1742-6723.13103","volume":"30","author":"A Latona","year":"2018","unstructured":"Latona A, Latona A. Meningococcal epiglottitis in a healthy adult patient: the first documented case in Australia. Emerg Med Australas. 2018;30(4):591\u20132. https:\/\/doi.org\/10.1111\/1742-6723.13103.","journal-title":"Emerg Med Australas"},{"key":"1281_CR103","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.steroids.2015.05.013","volume":"101","author":"M Levy","year":"2015","unstructured":"Levy M, Antunes A, Fiette L, Deghmane AE, Taha MK. Impact of corticosteroids on experimental meningococcal sepsis in mice. Steroids. 2015;101:96\u2013102. https:\/\/doi.org\/10.1016\/j.steroids.2015.05.013.","journal-title":"Steroids"},{"issue":"5","key":"1281_CR104","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.anl.2011.10.015","volume":"39","author":"S Sato","year":"2012","unstructured":"Sato S, Kuratomi Y, Inokuchi A. Pathological characteristics of the epiglottis relevant to acute epiglottitis. Auris Nasus Larynx. 2012;39(5):507\u201311. https:\/\/doi.org\/10.1016\/j.anl.2011.10.015.","journal-title":"Auris Nasus Larynx"},{"issue":"10","key":"1281_CR105","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1128\/IAI.00420-16","volume":"84","author":"J Bergounioux","year":"2016","unstructured":"Bergounioux J, Coureuil M, Belli E, Ly M, Cambillau M, Goudin N, et al. Experimental evidence of bacterial colonization of human coronary microvasculature and myocardial tissue during meningococcemia. Infect Immun. 2016;84(10):3017\u201323. https:\/\/doi.org\/10.1128\/IAI.00420-16.","journal-title":"Infect Immun"},{"issue":"5","key":"1281_CR106","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/clinids\/6.5.625","volume":"6","author":"MJ Blaser","year":"1984","unstructured":"Blaser MJ, Reingold AL, Alsever RN, Hightower A. Primary meningococcal pericarditis: a disease of adults associated with serogroup C Neisseria meningitidis. Rev Infect Dis. 1984;6(5):625\u201332. https:\/\/doi.org\/10.1093\/clinids\/6.5.625.","journal-title":"Rev Infect Dis"},{"key":"1281_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2022.e01634","volume":"30","author":"M Green","year":"2022","unstructured":"Green M, Harrison P, Sengupta A, Schlosshan D. A case report of primary meningococcal pericarditis secondary to Neisseria meningitidis in a young female patient. IDCases. 2022;30:e01634. https:\/\/doi.org\/10.1016\/j.idcr.2022.e01634.","journal-title":"IDCases"},{"issue":"3","key":"1281_CR108","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/17843286.2022.2107315","volume":"78","author":"G Moerman","year":"2023","unstructured":"Moerman G, Verleyen D, Rogiers P, Hoste J, Mattheus W, Flore K. Meningococcal pericarditis caused by the MenW:cc11 strain in an older adult. Acta Clin Belg. 2023;78(3):254\u20136. https:\/\/doi.org\/10.1080\/17843286.2022.2107315.","journal-title":"Acta Clin Belg"},{"issue":"2","key":"1281_CR109","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ecm1020013","volume":"1","author":"A Singh","year":"2024","unstructured":"Singh A. Meningococcal disease presenting with acute myopericarditis and concurrent acute meningitis. Emerg Care Med. 2024;1(2):95\u2013102. https:\/\/doi.org\/10.3390\/ecm1020013.","journal-title":"Emerg Care Med"},{"issue":"1","key":"1281_CR110","doi-asserted-by":"publisher","DOI":"10.1099\/jmmcr.0.005078","volume":"4","author":"F Gronthoud","year":"2017","unstructured":"Gronthoud F, Hassan I, Newton P. Primary pyogenic ventriculitis caused by Neisseria meningitidis: case report and review of the literature. JMM Case Rep. 2017;4(1):e005078. https:\/\/doi.org\/10.1099\/jmmcr.0.005078.","journal-title":"JMM Case Rep"},{"issue":"1","key":"1281_CR111","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12879-018-3119-4","volume":"18","author":"A Lesourd","year":"2018","unstructured":"Lesourd A, Magne N, Soares A, Lemaitre C, Taha MK, Gueit I, et al. Primary bacterial ventriculitis in adults, an emergent diagnosis challenge: report of a meningoccal case and review of the literature. BMC Infect Dis. 2018;18(1):226. https:\/\/doi.org\/10.1186\/s12879-018-3119-4.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1281_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2023.104694","volume":"53","author":"JP Stahl","year":"2023","unstructured":"Stahl JP, Canoui E, Pavese P, Bleibtreu A, Dubee V, Ferry T, et al. SPILF update on bacterial arthritis in adults and children. Infect Dis Now. 2023;53(4):104694. https:\/\/doi.org\/10.1016\/j.idnow.2023.104694.","journal-title":"Infect Dis Now"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01281-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-025-01281-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01281-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:27:16Z","timestamp":1769678836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-025-01281-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1281"],"URL":"https:\/\/doi.org\/10.1007\/s40121-025-01281-5","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Muhamed-Kheir Taha conducts work contracts funded by GSK, Pfizer, and Sanofi for the Institut Pasteur, Paris. He also reports the patent NZ630133A \u201cVaccines for serogroup X meningococcus\u201d issued with GSK. Catherine Weil-Olivier declares receiving fees, travel grants, and honoraria from Sanofi for attending scientific meetings and presentations on this topic. Sean Leng declares participation in Sanofi\u2019s International Advisory Board on SARS-CoV-2 vaccine development and engaged in speaking for GSK on Shingrix vaccine. Ener Cagri Dinleyici declares performing contract work (advisory board member, speaker and grant) for Eskisehir Osmangazi University, funded by GSK, Pfizer, MSD, and Sanofi Pasteur. Saber Yezli declares receiving consultation fees, travel grants, and honoraria from Sanofi for attending scientific meetings and presentations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}